Company Overview - IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry, formed through the merger of IMS Health and Quintiles [11] - The company operates in over 100 countries and employs approximately 87,000 people [11] Investment Ratings - IQVIA Holdings has a Zacks Rank of 3 (Hold) and a VGM Score of A, indicating a solid position in the market [12] - The Value Style Score is B, supported by attractive valuation metrics such as a forward P/E ratio of 16.44, which may appeal to value investors [12] Earnings Estimates - In the last 60 days, three analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate increasing to $11.84 per share [12] - The company has an average earnings surprise of 1.7%, suggesting a positive trend in earnings performance [12] Investment Considerations - With a strong Zacks Rank and favorable Value and VGM Style Scores, IQVIA Holdings is recommended for investors' consideration [13]
IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy?